Literature DB >> 15035968

Continuous glucose monitoring in type 1 diabetes.

Stuart A Weinzimer1, William V Tamborlane, H Peter Chase, Satish K Garg.   

Abstract

Continuous glucose monitoring is becoming increasingly more widespread for the routine care of people with type 1 diabetes mellitus and may eventually be used in closed-loop artificial beta-cell systems. The current "state of the art" of this technology, including accuracy, performance in clinical trials, limitations, and recommendations for use, is discussed for the two currently approved continuous glucose monitoring devices.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15035968     DOI: 10.1007/s11892-004-0063-z

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  17 in total

1.  Clinical utility of the continuous glucose monitoring system.

Authors:  B W Bode
Journal:  Diabetes Technol Ther       Date:  2000       Impact factor: 6.118

2.  Continuous subcutaneous glucose monitoring in children with type 1 diabetes.

Authors:  H P Chase; L M Kim; S L Owen; T A MacKenzie; G J Klingensmith; R Murtfeldt; S K Garg
Journal:  Pediatrics       Date:  2001-02       Impact factor: 7.124

3.  Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes.

Authors:  Francine Ratner Kaufman; Juliana Austin; Aaron Neinstein; Lily Jeng; Mary Halvorson; Debra J Devoe; Pisit Pitukcheewanont
Journal:  J Pediatr       Date:  2002-11       Impact factor: 4.406

4.  Use of the GlucoWatch biographer in children with type 1 diabetes.

Authors:  H Peter Chase; Mary D Roberts; Clare Wightman; Georgeanna Klingensmith; Satish K Garg; Michelle Van Wyhe; Shashi Desai; Wesley Harper; Margarita Lopatin; Miroslaw Bartkowiak; Janet Tamada; Richard C Eastman
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

5.  A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects.

Authors:  F R Kaufman; L C Gibson; M Halvorson; S Carpenter; L K Fisher; P Pitukcheewanont
Journal:  Diabetes Care       Date:  2001-12       Impact factor: 19.112

6.  The accuracy of the CGMS in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study.

Authors: 
Journal:  Diabetes Technol Ther       Date:  2003       Impact factor: 6.118

7.  Decreased epinephrine responses to hypoglycemia during sleep.

Authors:  T W Jones; P Porter; R S Sherwin; E A Davis; P O'Leary; F Frazer; G Byrne; S Stick; W V Tamborlane
Journal:  N Engl J Med       Date:  1998-06-04       Impact factor: 91.245

8.  Analysis of continuous glucose monitoring data from non-diabetic and diabetic children: a tale of two algorithms.

Authors:  Stuart A Weinzimer; Maria C DeLucia; Elizabeth A Boland; Amy Steffen; William V Tamborlane
Journal:  Diabetes Technol Ther       Date:  2003       Impact factor: 6.118

9.  Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes.

Authors:  Kilty McGowan; William Thomas; Antoinette Moran
Journal:  Diabetes Care       Date:  2002-09       Impact factor: 19.112

10.  Severe hypoglycemia in IDDM children.

Authors:  I Bergada; S Suissa; J Dufresne; A Schiffrin
Journal:  Diabetes Care       Date:  1989-04       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.